What is the role of acyclovir in managing an eczema flare?

Acyclovir Has No Role in Routine Eczema Flares

Acyclovir should NOT be used for typical eczema flares, but is critically important and potentially life-saving when eczema is complicated by herpes simplex virus superinfection (eczema herpeticum).

When Acyclovir IS Indicated: Eczema Herpeticum

Eczema herpeticum is a dermatologic emergency that transforms acyclovir from irrelevant to essential. This condition represents disseminated herpes simplex virus infection in patients with atopic dermatitis and historically carried a 10-50% mortality rate before antiviral therapy 1.

Key clinical features to recognize eczema herpeticum:

• Sudden onset of painful, punched-out erosions or vesicles
• Monomorphic appearance (unlike typical eczema)
• Clustered or disseminated distribution
• Often accompanied by fever and systemic symptoms
• May involve ocular disease requiring urgent treatment 2

Treatment Protocol for Eczema Herpeticum

Systemic acyclovir is the standard of care 1, 3:

• Oral acyclovir 200 mg five times daily for 5 days in mild-moderate cases 3
• IV acyclovir 5-10 mg/kg every 8 hours for severe disease or complications 4
• Earlier initiation directly correlates with shorter hospital stays 1

The evidence is compelling: a multicenter trial demonstrated 81.3% efficacy with acyclovir versus 42.9% with placebo (p<0.01) 3. Most importantly, no deaths occurred from eczema herpeticum when patients received systemic antiviral therapy in a large retrospective review of 1,331 children 1.

For ocular involvement, combine systemic acyclovir with topical trifluridine—this combination resolves keratitis within 48-72 hours without scarring 2.

When Acyclovir Is NOT Indicated: Routine Eczema Flares

Standard eczema flares are inflammatory, not viral. The 2014 AAD guidelines on atopic dermatitis management 1 and the 2024 AAAAI/ACAAI guidelines 5 make no mention of acyclovir for routine flare management because it has no role.

Appropriate management of uncomplicated eczema flares includes:

• Topical corticosteroids (first-line)
• Topical calcineurin inhibitors
• Barrier repair with emollients
• Identification and avoidance of triggers

Critical Pitfall to Avoid

Do not confuse bacterial superinfection with viral superinfection. While Staphylococcus aureus colonization is common in atopic dermatitis and may warrant systemic antibiotics when frank infection is present 1, this is entirely different from eczema herpeticum. The clinical presentations differ markedly:

• Bacterial infection: honey-crusted lesions, weeping, impetiginization
• Eczema herpeticum: punched-out erosions, vesicles, monomorphic appearance

Practical Algorithm

1. Assess the flare clinically:

   • Typical eczema appearance (erythema, scaling, lichenification)? → Standard topical therapy
   • Sudden onset punched-out erosions/vesicles with pain? → Suspect eczema herpeticum

2. If eczema herpeticum suspected:

   • Initiate systemic acyclovir immediately (do not wait for viral culture)
   • Consider hospitalization for severe cases, immunocompromised patients, or ocular involvement
   • Viral culture/PCR can confirm but should not delay treatment

3. If typical bacterial superinfection:

   • Systemic antistaphylococcal antibiotics, not acyclovir
   • Continue appropriate topical anti-inflammatory therapy

The distinction is critical: acyclovir transforms from irrelevant to life-saving based solely on whether HSV superinfection is present. The evidence from multiple sources 1, 3, 2, 6, 7 consistently demonstrates that while acyclovir has no role in routine eczema management, it is essential for eczema herpeticum with documented mortality reduction.